SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Cipla Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500087 INE059A01026 397.3891536 CIPLA 1.02 126,732.58 24.53 63.96 2
Quarters :
ParticularsJun 2025(Rs.Cr)Mar 2025(Rs.Cr)Dec 2024(Rs.Cr)
Gross Sales4501.664254.474134.87
Other Operating Income544.51543.42836.01
Other Income 271.07588.03188.69
Total Income5317.245385.925159.57
Total Expenditure 3421.723479.183309.05
PBIDT1895.521906.741850.52
Interest 5.883.493.55
PBDT1889.641903.251846.97
Depreciation145.69147.70142.62
Tax456.04332.71262.96
Fringe Benefit Tax0.000.000.00
Deferred Tax-15.22-62.563.24
Reported Profit After Tax1303.131485.401438.15
Extra-ordinary Items 0.00238.820.00
Adjusted Profit After Extra-ordinary item1303.131246.581438.15
    
EPS (Unit Curr.)16.1318.3917.81
EPS (Adj) (Unit Curr.)16.1318.3917.81
Calculated EPS (Unit Curr.)16.1318.3917.81
Calculated EPS (Adj) (Unit Curr.)16.1318.3917.81
Calculated EPS (Ann.) (Unit Curr.)64.5373.5771.23
Calculated EPS (Adj) (Ann.) (Unit Curr.)64.5373.5771.23
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity161.55161.52161.52
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)42.1144.8244.75
PBDTM(%)41.9844.7444.67
PATM(%)28.9534.9134.78